WHO ICTRP trial

A comparative clinical trial to test efficacy and safety of 2 brands of highly…

CTRI/2009/091/000854 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2009/091/000854
Public title A comparative clinical trial to test efficacy and safety of 2 brands of highly purified human menopausal gonadotropins in subjects undergoing their first cycle of IVF
Scientific title A prospective, multicenter, randomized, open, comparative clinical trial to test efficacy and safety of 2 brands of highly purified human menopausal gonadotropins in subjects undergoing their first cycle of invitro fertilization with intracytoplasmic sperm injection (ICSI)
Primary sponsor Bharat Serums and Vaccines Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type Interventional
Phase Phase 3
Countries India
Interventions Intervention1: Highly purified human menopausal gonadotropin - Test drug: 2 to 4 vials of 75 IU will be administered subcutaneously per day for about 8 - 12 days Control Intervention1: Highly purified Human Menopausal Gonadotropin…
Registration date Jun 17, 2010
Target size 100
Secondary IDs BSV/Humog-HP/09
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations